Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Timeline Of Pharma Provisions In Health Care Reform

This article was originally published in The Pink Sheet Daily

Executive Summary

A recap of provisions affecting biopharma and key implementation deadlines.

The final piece of health care reform legislation, the budget reconciliation bill, is now on the president's desk for signature. Seen as an overall positive for the biopharma industry, the package includes several dozen provisions that revise government prescription drug programs or expand drug access by expanding the market of insured individual (Also see "Final Health Reform Bill Looks Positive For Pharma Firms" - Pink Sheet, 22 Mar, 2010.).

This chart, 'Timeline of Pharma Provisions In Health Care Reform,' recaps these provisions and identifies key implementation dates.

- Scott Steinke ([email protected])

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS070416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel